Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M298Revenue (TTM) $M1.8Net Margin (%)-2,413.6Altman Z-Score6.5
Enterprise Value $M218EPS (TTM) $-1.8Operating Margin %-2,334.1Piotroski F-Score4
P/E(ttm)--Beneish M-Score-2.8Pre-tax Margin (%)-2,413.6Higher ROA y-yY
Price/Book3.710-y EBITDA Growth Rate %--Quick Ratio16.2Cash flow > EarningsY
Price/Sales1595-y EBITDA Growth Rate %--Current Ratio16.2Lower Leverage y-yY
Price/Free Cash Flow--y-y EBITDA Growth Rate %--ROA % (ttm)-40.5Higher Current Ratio y-yY
Dividend Yield %--PEG--ROE % (ttm)-50.0Less Shares Outstanding y-yN
Payout Ratio %--Shares Outstanding M24.8ROIC % (ttm)-99,504.8Gross Margin Increase y-yN

Gurus Latest Trades with OCUL

Number of guru portfolios checked: 68.
No Entry found in the selected group of Gurus. You can

OCUL is held by these investors:

No Entry found in the selected group of Gurus. You can
Premium Most recent portfolio changes are included for Premium Members only!


OCUL: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
Sawhney AmarpreetPresident and CEO, 10% Owner 2015-11-17Buy10,000$8.2546.06view
Fortune JamesCOO 2015-09-15Sell9,470$17.16-29.78view
Sawhney AmarpreetPresident and CEO, 10% Owner 2015-09-14Buy15,000$16.5-26.97view
Versant Venture Capital III, L10% Owner 2015-06-15Sell320,000$22-45.23view
Warden Charles MDirector, 10% Owner 2015-06-15Sell320,000$22-45.23view
SVLSF IV, LLC10% Owner 2015-06-10Sell1,119,000$22-45.23view
Versant Venture Capital III, L10% Owner 2015-06-10Sell427,000$22-45.23view
Warden Charles MDirector, 10% Owner 2015-06-10Sell427,000$22-45.23view
Polaris Venture Management Co.10% Owner 2015-02-02Sell500,000$29.5-59.15view
SVLSF IV, LLC10% Owner 2014-07-30Buy715,380$13-7.31view

Quarterly/Annual Reports about OCUL:

    News about OCUL:

    Articles On GuruFocus.com
    Weekly CEO Buys Highlight: APD, OCUL, CNMD, OPK, AEGR Aug 04 2014 

    More From Other Websites
    OCULAR THERAPEUTIX, INC Financials May 19 2016
    Edited Transcript of OCUL earnings conference call or presentation 10-May-16 12:00pm GMT May 10 2016
    Ocular Therapeutix Inc Earnings Call scheduled for 8:00 am ET today May 10 2016
    OCULAR THERAPEUTIX, INC Files SEC form 8-K, Results of Operations and Financial Condition, Financial... May 10 2016
    Ocular Therapeutix™ Reports First Quarter 2016 Financial Results and Provides Corporate Update May 10 2016
    Ocular Therapeutix reports 1Q loss May 10 2016
    Ocular Therapeutix reports 1Q loss May 10 2016
    Q1 2016 Ocular Therapeutix Inc Earnings Release - Before Market Open May 10 2016
    Ocular Therapeutix™ Reports First Quarter 2016 Financial Results and Provides Corporate Update May 10 2016
    Ocular Therapeutix™ to Report First Quarter 2016 Financial Results May 03 2016
    Ocular Therapeutix™ to Report First Quarter 2016 Financial Results May 03 2016
    Ocular TherapeutixTM Completes End-of-Phase 2 Review with FDA for OTX-TP (Sustained Release... Apr 27 2016
    Ocular TherapeutixTM Completes End-of-Phase 2 Review with FDA for OTX-TP (Sustained Release... Apr 27 2016
    ETF’s with exposure to Ocular Therapeutix, Inc. : April 8, 2016 Apr 08 2016
    5 stocks to watch Apr 06 2016
    Can The Uptrend Continue for Ocular Therapeutix (OCUL)? Apr 05 2016
    7 Stocks Under $10 to Trade for Breakout Gains Mar 30 2016
    Ocular TherapeutixTM to Host Investor Day on April 6, 2016 Mar 28 2016
    Ocular TherapeutixTM to Host Investor Day on April 6, 2016 Mar 28 2016
    These 7 Stocks Under $10 Are Set to Soar Higher Mar 18 2016

    Add Notes, Comments

    If you want to ask a question or report a bug, please create a support ticket.
    Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
    GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)